Loading...

383 posters, 2 videos, 1 audios, 8 topics, 28 sessions, 328 authors, 225 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

6361

SUPERIOR CLUNEAL NERVE BLOCKS OFFER A VIABLE OPTION FOR ACUTE FLARE-UP OF CHRONIC AXIAL LOWER BACK PAIN

Part of Topic

Scientific Abstracts > Chronic Pain

Superior cluneal nerve blocks offer a viable option for acute flare-up of chronic axial lower back pain

Introduction

Lower back pain (LBP) is a common cause of discomfort, dysfunction, and disability worldwide. A growing body of research suggests that superior cluneal neuralgia is a notable cause of axial LBP.1 Superior cluneal neuralgia can be managed with lifestyle modifications, physiotherapy, and pharmacological treatments.2 If conservative management fails to provide sufficient pain relief, patients may elect to proceed with diagnostic and therapeutic superior cluneal nerve (SCN) blocks with local anesthetic and steroid for longer duration pain relief.2 Additional interventional options include radiofrequency ablation (RFA), peripheral nerve stimulation, and surgical decompression for SCN entrapment.3-5

Methods

We present four cases of axial LBP in patients without history of lumbar laminectomy or fusion who were treated with bilateral SCN blocks under fluoroscopy from 2023 to 2024. Each patient reported unsatisfactory pain relief from pharmacotherapy, physiotherapy, complementary and alternative medicine. On examination, all four patients had positive lumbar facet loading tests and marked tenderness to palpation over bilateral iliac crest that correlated with the SCN distribution. Nerve blocks were directed at three targets along the lateral, medial, and middle superior borders of each iliac crest with 1.5-mL 10 mg/ml dexamethasone and 4.5 or 7.5-mL 0.25% bupivacaine for 1.0 or 1.5-mL aliquots, respectively (Image 1). This abstract is devoid of patient identifiable information and therefore exempt from IRB review requirements per UCLA policy. Informed consent was obtained from each patient.

Case Report

1.Case 1: 73-year-old female with a pain severity numeric rating scale (NRS) at 8/10. Reported 50% pain relief after bilateral lumbar medial branch RFA multiple times previously with the most recent 3-months prior. After receiving bilateral SCN blocks with 1.0-mL aliquots, reported 80% pain relief for 10 weeks and endorsed superior pain relief than their prior RFA.
2.Case 2: 66-year-old female with a NRS at 9/10. Reported insignificant pain relief after a left lumbar medial branch RFA 6-months prior. After receiving bilateral SCN blocks with 1.5-mL aliquots, reported 50% pain relief for 2 weeks.
3.Case 3: 61-year-old female with a NRS at 10/10. Reported 50% pain relief for 3 months after bilateral lumbar medial branch RFA’s 10-years prior. After receiving bilateral SCN blocks with 1.5-mL aliquots, reported 80% pain relief for 4 weeks.
4.Case 4: 47-year-old female with a NRS at 8/10. Reported significant pain relief after a lumbar medial branch RFA 2-years prior. After receiving bilateral SCN blocks with 1.0-mL aliquots, reported 70% pain relief for 4 weeks.

Discussion

Each patient described 50% or greater pain relief for at least two weeks after SCN blocks. These patients had early analgesia onset and short recovery times that fostered their ability to engage in physiotherapy and functional restoration. SCN blocks offer a viable option for acute flare-up of chronic axial LBP when facet medial branch blocks or RFA do not provide significant or long-lasting pain relief. Currently, there is a paucity of literature examining the inclusion criteria for SCN blocks as an interventional pain procedure. Future comparative clinical studies may help to identify optimum candidates and timing for SCN procedures to facilitate clinical progress.

asraspring2025 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.